Home > Healthcare > Medical Devices > Therapeutic Devices > Left Atrial Appendage Closure Devices Market

Left Atrial Appendage Closure Devices Market Share

  • Report ID: GMI3960
  • Published Date: Nov 2022
  • Report Format: PDF

Left Atrial Appendage Closure Devices Market Share

The left atrial appendage closure devices market includes prominent companies such as :

  • Boston Scientific Corporation
  • LifeTech Scientific
  • Occlutech
  • Johnson & Johnson
  • AtriCure, Inc.
  • Abbott Laboratories, Inc

Significant R&D expenditures by manufacturers toward diversifying their product offerings are aiding market development. For instance, in August 2021, healthcare giant Abbott Laboratories’ Amplatzer Amulet Left Atrial Appendage Occluder received U.S. FDA approval to meet the clinical demands of atrial fibrillation (AFib) patients.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for left atrial appendage closure devices was valued at over USD 1.4 billion in 2022 and is projected to expand at 12.5% CAGR through 2032.

Percutaneous segment is projected to depict over 12.5% CAGR through 2032. This surgical procedure requires a minor incision and leaves minimal scars, which has impelled segment progress.

North America left atrial appendage closure devices market held over 46% industry share in 2022 and is estimated to observe notable progress through 2032 owing to the growing incidences of accidental injuries and the expanding geriatric population.

Prominent firms operating in the left atrial appendage closure devices industry include Boston Scientific Corporation, LifeTech Scientific, Johnson & Johnson, AtriCure, Inc., Occlutech, Abbott Laboratories, Inc., and others.

Left Atrial Appendage Closure Devices Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 8
  • Tables & Figures: 361
  • Countries covered: 18
  • Pages: 201
 Download Free Sample